Today: 19 March 2026
Subscribe
Browse Category

NASDAQ:AMD 24 February 2026 - 13 March 2026

AMD stock price falls 2% as oil tops $100, Meta chip plans and Nvidia GTC loom

AMD stock price falls 2% as oil tops $100, Meta chip plans and Nvidia GTC loom

AMD shares fell 2.2% to $193.39 Friday as semiconductor stocks slid and the Nasdaq dropped 0.9%, with Brent crude closing above $100 a barrel. Nvidia lost 1.6%, while Intel rose 1.2%. AMD CEO Lisa Su is set to meet Samsung’s Jay Y. Lee next week to discuss high-bandwidth memory amid ongoing supply shortages. Meta unveiled four in-house AI chips but will continue buying from AMD and Nvidia.
13 March 2026
····
AMD Stock Price Drops Below $200 as Oil Shock Hits Chip Shares, Meta Expands In-House AI Push

AMD Stock Price Drops Below $200 as Oil Shock Hits Chip Shares, Meta Expands In-House AI Push

AMD shares fell 3.4% to $197.74 late Thursday, dropping below $200 as tech stocks slid amid a broader market selloff. The decline followed Iranian strikes on oil tankers that pushed crude prices higher and rattled Wall Street. Meta unveiled new in-house AI chips and confirmed a $60 billion AMD chip deal, while AMD CEO Lisa Su plans to visit South Korea next week for memory supply talks.
13 March 2026
·····
Meta Stock Week Ahead: Why CPI, EU Pressure and AI Costs Could Drive the Next Move

Meta Stock Week Ahead: Why CPI, EU Pressure and AI Costs Could Drive the Next Move

Meta Platforms shares closed at $644.86 Friday, down 2.4%, after agreeing to allow rival AI chatbots on WhatsApp in Europe for a year amid ongoing EU antitrust scrutiny. The company faces rising costs, with 2026 capital spending projected up to $135 billion. Meta has secured major AI chip deals with AMD and Google. Regulatory pressures increased as Indonesia and an Indian state moved to restrict social media for minors.
7 March 2026
········
Advanced Micro Devices (AMD) Faces Fresh U.S. AI Chip Export Risk as Washington Weighs New Rules

Advanced Micro Devices (AMD) Faces Fresh U.S. AI Chip Export Risk as Washington Weighs New Rules

U.S. officials are drafting new AI chip export rules that could require foreign governments to invest in U.S. data centers or provide security guarantees before buying large volumes, potentially affecting AMD, Nvidia, and Intel. The proposal follows AMD’s $60 billion chip deal with Meta and comes as tech giants plan over $600 billion in AI infrastructure spending this year. The draft is not final.
5 March 2026
···
AMD teams up with University of Toronto for 100-project AI research lab in Canada

AMD teams up with University of Toronto for 100-project AI research lab in Canada

AMD and the University of Toronto opened a joint AI and computing research lab, with AMD committing to fund 100 projects over three years and donating two AI servers. The lab will focus on energy-efficient AI systems and methods for training large models on distributed clusters. Federal and provincial officials attended the launch. AMD shares fell about 1% in morning trading.
5 March 2026
···
AMD teams up with University of Toronto on new AI research lab as chip race heats up

AMD teams up with University of Toronto on new AI research lab as chip race heats up

AMD and the University of Toronto opened a new AI and computing research lab, planning to support 100 projects over three years and add new AI servers. AMD shares rose nearly 6% in premarket trading as investors watched its AI chip efforts. The lab joins AMD’s R&D network, which includes MIT and UC Berkeley. Executives also reported recent share sales linked to equity awards.
5 March 2026
·
AMD stock price slides nearly 5% today as chip shares sink — here’s what’s driving it

AMD stock price slides nearly 5% today as chip shares sink — here’s what’s driving it

AMD shares fell 4.8% to $189.16 by midmorning Tuesday amid a broad tech selloff, with Nvidia down 2.8% and Intel off 6.3%. Flex began U.S. manufacturing of AMD’s Instinct MI355X GPU platform in Austin, Texas, with volume ramping next quarter. Wall Street indexes dropped over 2% as investors reacted to Middle East tensions and rising oil prices. AMD CTO Mark Papermaster was set to speak at a Morgan Stanley conference.
3 March 2026
·
Nvidia stock slides again, dragging AI shares as Wall Street questions the payoff

Nvidia stock slides again, dragging AI shares as Wall Street questions the payoff

Nvidia shares fell 2.4% Friday, extending losses after a steep drop post-earnings, and pulling other AI-linked tech stocks lower. The Dow dropped 1.22%, S&P 500 lost 0.66%, and Nasdaq slid 0.99% in late morning trading. Hotter-than-expected U.S. producer prices fueled inflation concerns and pressured high-valuation tech names. Global equity fund inflows hit a five-week low as investors grew cautious.
27 February 2026
·····
Why AMD stock is down: hot U.S. wholesale inflation and Nvidia slump weigh on Advanced Micro Devices

Why AMD stock is down: hot U.S. wholesale inflation and Nvidia slump weigh on Advanced Micro Devices

Advanced Micro Devices shares fell 1.6% to $200.43 in mid-morning New York trade Friday, tracking declines across chip stocks after U.S. producer prices rose 0.5% in January, above forecasts. The Philadelphia Semiconductor Index dropped about 1.1%. Nvidia shares also fell Thursday despite strong results. Investors are watching for Broadcom earnings March 4 and the U.S. jobs report March 6.
27 February 2026
·····
AMD stock slips after Meta AI-chip pact as Nutanix tie-up lands

AMD stock slips after Meta AI-chip pact as Nutanix tie-up lands

AMD shares fell 2.6% to $205.31 Thursday morning after the company announced a $150 million investment in Nutanix and up to $100 million for joint AI platform work. The drop followed news of a five-year deal to sell up to $60 billion in AI chips to Meta, which includes a performance-based warrant for Meta to buy up to 160 million AMD shares at $0.01 each.
26 February 2026
·····
Nutanix stock jumps 22% premarket after AMD takes $150 million stake in AI partnership

Nutanix stock jumps 22% premarket after AMD takes $150 million stake in AI partnership

Nutanix shares rose 22% premarket to $47.01 after AMD agreed to buy $150 million in Nutanix stock and jointly develop an enterprise AI platform. Nutanix posted Q2 revenue of $722.8 million and raised its full-year outlook to $2.80–$2.84 billion. Supply-chain issues may delay some revenue and cash flow, the company said. AMD’s investment involves a private placement at $36.26 per share.
26 February 2026
··
Meta stock rises after $60 billion AMD AI chip pact, with Nvidia earnings next

Meta stock rises after $60 billion AMD AI chip pact, with Nvidia earnings next

Meta Platforms shares rose about 1.4% Wednesday after Reuters reported a deal to buy up to $60 billion of AMD AI chips over five years. The agreement includes a warrant for Meta to acquire up to 10% of AMD if certain GPU shipment milestones are met. Investors are awaiting Nvidia’s quarterly results for further signals on AI hardware demand.
25 February 2026
····
AMD stock rises in premarket as Meta AI-chip pact puts 160 million-share warrant under a microscope

AMD stock rises in premarket as Meta AI-chip pact puts 160 million-share warrant under a microscope

AMD rose about 0.8% to $215.50 in premarket trading Wednesday after announcing a multi-year deal with Meta to supply up to 6 gigawatts of Instinct GPUs. Meta received a performance-based warrant for up to 160 million AMD shares, vesting in tranches tied to chip shipments and stock-price targets. Reuters reported the agreement could reach $60 billion over five years.
25 February 2026
·····
AMD stock steadies before the open after Meta AI chip deal, 160 mln-share warrant

AMD stock steadies before the open after Meta AI chip deal, 160 mln-share warrant

AMD shares rose 0.4% in premarket trading after announcing a five-year AI chip supply deal with Meta worth up to $60 billion. The agreement gives Meta a warrant to buy up to 10% of AMD stock at $0.01 per share, tied to shipment and stock-price milestones. The deal comes hours before Nvidia’s earnings report, which investors are watching for AI chip demand signals.
25 February 2026
·····
Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

Stock market today: Dow futures steady as AI scare cools, Nvidia earnings and Trump tariffs loom

Japan’s Nikkei jumped 2.2% to 58,583.12 and the S&P 500 closed up 0.8% as Wall Street rebounded from a tech-led selloff. Anthropic launched 10 new AI plug-ins, boosting partner stocks such as Thomson Reuters and FactSet. AMD shares rose after a $60 billion AI chip deal with Meta. The U.S. began collecting a temporary 10% global import tariff, with a possible increase to 15% under consideration.
25 February 2026
··········
AMD stock jumps after-hours as Meta signs up for $60 billion AI chip deal and stake option

AMD stock jumps after-hours as Meta signs up for $60 billion AI chip deal and stake option

AMD shares rose 8.8% to $213.84 after Meta agreed to buy up to 6 gigawatts of AMD AI chips in a multi-year deal, with first shipments set for late 2026. The agreement includes a warrant allowing Meta to buy up to 10% of AMD shares at $0.01 each, tied to delivery and price milestones. Meta stock was little changed. Investors now await Nvidia’s earnings on Wednesday.
24 February 2026
··
1 2 3 … 29

Stock Market Today

  • Soligenix Publishes HyBryte Clinical Data Validating Safety and Efficacy
    March 19, 2026, 2:04 PM EDT. Soligenix (NASDAQ: SNGX), a biopharmaceutical firm targeting rare diseases, reported the publication of clinical trial data on HyBryte (synthetic hypericin) in the peer-reviewed journal Expert Opinion on Investigational Drugs. The summary underscores HyBryte's safety profile, non-mutagenic mechanism, and demonstrated efficacy against cutaneous T-cell lymphoma (CTCL). The data supports HyBryte's potential as a first-line treatment. Soligenix continues its ongoing FLASH2 Phase 3 trial for HyBryte, with an interim analysis slated for Q2 2026. The company focuses on rare disease therapies and vaccine programs underpinned by proprietary technology. This publication bolsters investor confidence as Soligenix advances regulatory efforts toward global commercialization of HyBryte, expanding its pipeline across inflammatory and infectious diseases.
Go toTop